Skip to content

Revealing the differences in vaginal micobiota among health women, patients with cervical intraepithelial neoplasia and Patients with cervical cancer using high-throughput sequencing

Revealing the differences in vaginal micobiota among health women, patients with cervical intraepithelial neoplasia and Patients with cervical cancer using high-throughput sequencing

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028419
Enrollment
Unknown
Registered
2019-12-21
Start date
2018-07-01
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Normal control group, cervical cancer group, cervical intraepithelial neoplasia group:Dorsal vaginal discharge

Sponsors

The Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Pathologically confirmed cervical cancer, CIN patients, and women of reproductive age.

Exclusion criteria

Exclusion criteria: 1. Poor adherence to antibiotics within 2 months combined with other diseases: heart disease, hypertension, and other infectious diseases. no mental illness, good compliance; 2. Smokeless alcohol hobby; 3. With hypertension, diabetes, tuberculosis and other diseases; 4. With history of cervical treatment.

Design outcomes

Primary

MeasureTime frame
Vaginal microbial diversity;

Countries

China

Contacts

Public ContactBuzhen Tan

The Second Affiliated Hospital of Nanchang University

buzhentan@sina.com+86 13979191592

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026